We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

51 hedge funds and large institutions have $57.2M invested in VanEck Pharmaceutical ETF in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

6% less funds holding

Funds holding: 54 → 51 (-3)

9% less capital invested

Capital invested by funds: $62.9M → $57.2M (-$5.76M)

9.34% less ownership

Funds ownership: 27.43% → 18.09% (-9.3%)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

58% less call options, than puts

Call options by funds: $866K | Put options by funds: $2.07M

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
16
Reduced
9
Closed
6
Calls
$866K
Puts
$2.07M
Net Calls
-$1.2M
Net Calls Change
-$887K

Top Buyers

Rank Fund Capital Flow
1
CCP
Clough Capital Partners
Massachusetts
+$6.94M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.34M
3
Vontobel Holding
Vontobel Holding
Switzerland
+$261K
4
Morgan Stanley
Morgan Stanley
New York
+$160K
5
UBS Group
UBS Group
Switzerland
+$96.5K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$3M
2
Osaic Holdings
Osaic Holdings
Arizona
-$1.89M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.19M
4
TRCT
Tower Research Capital (TRC)
New York
-$886K
5
RJA
Raymond James & Associates
Florida
-$264K
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
26
Harbour Investments
Wisconsin
$171K +$373 +5 +0.2%
TWM
27
Tradition Wealth Management
Minnesota
$170K +$76.9K +1,031 +79%
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$148K – – –
Barclays
29
Barclays
United Kingdom
$109K -$231K -3,094 -67%
MA
30
Montag & Associates
Georgia
$100K – – –
LWM
31
Liberty Wealth Management
California
$90K +$45.3K +607 +101%
TCM
32
Tradewinds Capital Management
Washington
$73K – – –
GT
33
Glenmede Trust
Pennsylvania
$72K – – –
NSIM
34
North Star Investment Management
Illinois
$71K – – –
KPCM
35
Kings Point Capital Management
New York
$44K +$44.8K +600 New
LS
36
Leelyn Smith
Illinois
$33K – – –
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$29.1K – – –
S
38
SignatureFD
Georgia
$26K – – –
Citigroup
39
Citigroup
New York
$22K -$10.1K -135 -31%
IA
40
IFP Advisors
Florida
$21K +$820 +11 +5%
AF
41
Advisornet Financial
Minnesota
$21K +$3.43K +46 +19%
EIP
42
Ellis Investment Partners
Pennsylvania
$19K – – –
ADL
43
Asset Dedication LLC
California
$16K +$5K +67 +46%
Fidelity Investments
44
Fidelity Investments
Massachusetts
$15K – – –
JCM
45
Jacobi Capital Management
Pennsylvania
$15K – – –
HCM
46
Highlander Capital Management
New Jersey
$10K – – –
NC
47
NewSquare Capital
Pennsylvania
$7K +$7.24K +97 New
SPIA
48
Steward Partners Investment Advisory
New York
$6K – – –
AIM
49
Anchor Investment Management
South Carolina
$4.22K – – –
SWA
50
SOA Wealth Advisors
New York
$2K – – –
1
2
3

PPH Hedge Fund Activity: Q3 2021 in Review

51 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q3 2021, worth a combined $57.2M — down 9.2% from $62.9M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of PPH and 4 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 16 added.

The largest buyer was Clough Capital Partners, opening a new position worth an estimated $6.94M. The largest seller was Bank of America, cutting an estimated $3M.

  • 51 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q3 2021, down from 54 in Q2 2021.
  • Funds reported $57.2M of VanEck Pharmaceutical ETF stock for Q3 2021, down 9.2% quarter-over-quarter.
  • 4 funds opened new VanEck Pharmaceutical ETF positions in Q3 2021 and 6 closed out, a net change of -2 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q3 2021 was Clough Capital Partners, an estimated $6.94M added.
  • The largest VanEck Pharmaceutical ETF seller in Q3 2021 was Bank of America, an estimated $3M sold.

Based on aggregated 13F filings for Q3 2021.